National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 22822-22823 [2014-09424]
Download as PDF
<![CDATA[
22822
Federal Register / Vol. 79, No. 79 / Thursday, April 24, 2014 / Notices
Publications
1. Akahata W, et al. A virus-like particle
vaccine for epidemic Chikungunya
virus protects non-human primates
against infection. Nat Med. 2010
Mar;16(3):334–8. [PMID 20111039]
2. Akahata W, Nabel GJ. A specific
domain of the Chikungunya virus
E2 protein regulates particle
formation in human cells:
implications for alphavirus vaccine
design. J Virol. 2012
Aug;86(16):8879–83. [PMID
22647698]
3. Chang et al. Chikungunya Virus-Like
Particle Vaccine Elicits Neutralizing
Antibodies in Healthy Adults in a
Phase I Clinical Trial; manuscript
submitted.
Intellectual Property
• HHS Reference Nos. E–004–2009/0/1/
2—
—US Provisional Application No. 61/
118,206 filed 26 Nov 2008
—US Provisional Application No. 61/
201,118 filed 05 Dec 2008
—International Application No. PCT/
US2009/006294 (WO 2010/062396)
filed 24 Nov 2009
—and corresponding filings in the US,
Europe, China, Australia, Brazil,
India, Malaysia, South Africa,
Singapore, Indonesia, Philippines and
Vietnam
• HHS Reference No. E–057–2011/0/1/
2—
—US Provisional Application No. 61/
438,236 filed 31 Jan 2011
—International Application No. PCT/
US2012/023361 (WO 2012/106356)
filed 31 Jan 2012
—and corresponding filings in the US
and India
Licensing Contact: Cristina
Thalhammer-Reyero, Ph.D., MBA; 301–
435–4507; ThalhamC@mail.nih.gov
Dated: April 21, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–09354 Filed 4–23–14; 8:45 am]
BILLING CODE 4140–01–P
pmangrum on DSK3VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Mar<15>2010
14:19 Apr 23, 2014
Jkt 232001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–137:
Light at Night.
Date: May 20, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Drugs, Alcohol and Heavy Metals.
Date: May 21–22, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Molecular
Genetics B Study Section.
Date: May 28–29, 2014.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Admiral Fell Inn, 888 South
Broadway, Baltimore, MD 21231.
Contact Person: Richard A. Currie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, (301) 435–
1219, currieri@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Genome x Environment.
Date: May 29–30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Time: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Melinda Jenkins, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
MSC 7770, Bethesda, MD 20892, 301–437–
7872, jenkinsml2@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Cellular and
Molecular Immunology—B Study Section.
Date: May 29–30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Betty Hayden, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social Sciences and Population Studies A
Study Section.
Date: May 29, 2014.
Time: 8:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact Person: Suzanne Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1712, ryansj@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 21, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–09353 Filed 4–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\24APN1.SGM
24APN1
Federal Register / Vol. 79, No. 79 / Thursday, April 24, 2014 / Notices
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, 2014–10 NIBIB K
and R13 Review.
Date: July 2, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Suite 957, Bethesda, MD 20892,
301–496–4773, zhour@mail.nih.gov.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–09424 Filed 4–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse
Notice of May Advisory Council on
Drug Abuse Meeting
Pursuant to the NIH Reform
Act of 2006 (42 U.S.C. Sec. 281(d)(4)),
notice is hereby given that the National
Institute on Drug Abuse (NIDA) will
host a meeting to enable public
discussion on the Institute’s proposal to
reorganize its extramural program in
establishment of a Division of
Extramural Research. The proposal
seeks to clearly delineate functions and
streamline the services provided within
the Office of the Director, as well as
capitalize on emerging scientific
opportunities, while reducing barriers to
scientific and interdisciplinary
collaboration.
SUMMARY:
This public meeting will take
place on May 7, 2014 with attendance
limited to space available. Any
interested person may file written
comments by sending an email to
NIDADERComment@mail.nih.gov, by
May 12, 2014. The statement should
include the individual’s name, contact
information and, when applicable,
professional affiliation.
ADDRESSES: Neuroscience Center,
Conference Rooms C & D, 6001
Executive Boulevard, Rockville,
Maryland 20852.
FOR FURTHER INFORMATION CONTACT:
Dave Daubert, Deputy Executive Officer,
National Institute on Drug Abuse, Office
of the Director, 6001 Executive
Boulevard, NSC Building, Room 5274,
Bethesda, MD 20892, 301–402–1652,
daubert@nih.gov.
pmangrum on DSK3VPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
14:19 Apr 23, 2014
Jkt 232001
Members
of the public wishing to attend must
RSVP to the contact person on this
notice by May 5, 2014. NIH has
instituted stringent procedures for
entrance onto the NIH campus and
constituent facilities. Visitors will be
asked to show one form of identification
(for example a government-issued photo
ID, valid driver’s license, or passport)
and to state the purpose of their visit.
Additionally, individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person by the
deadline provided above in advance of
the meeting.
Individuals will also be able to view
the meeting via NIH Videocast. Please
go to the following link for Videocast
access instructions at: https://
videocast.nih.gov/faq/#setup.
A portion of this meeting will be
closed to the public. Information is
available on the Institute’s Web site,
https://www.drugabuse.gov/news-events/
meetings-events/2014/05/nationaladvisory-council-drug-abuse, where
details on the agenda and any additional
information for the meeting will be
posted when available. A portion of the
agenda will include: A report by the
Director, NIDA and a public discussion
on the proposed reorganization plans for
NIDA extramural program.
SUPPLEMENTARY INFORMATION:
Dated: April 17, 2014.
Nora Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2014–09285 Filed 4–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
22823
Name of Committee: National Institute on
Aging Special Emphasis Panel; Juvenile
Protective Factor (JPF).
Date: May 22, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building 2C212, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Branch, National Institute
On Aging, Gateway Bldg., 2C212, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 21, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–09352 Filed 4–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 79, Number 79 (Thursday, April 24, 2014)]
[Notices]
[Pages 22822-22823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09424]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 22823]]
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel, 2014-10 NIBIB K and R13
Review.
Date: July 2, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, Suite
920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer,
6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892, 301-496-
4773, zhour@mail.nih.gov.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-09424 Filed 4-23-14; 8:45 am]
BILLING CODE 4140-01-P
